Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ester Aso

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Current Pharmaceutical Design|November 5, 2013
Genetically modified mice as tools to understand the neurobiological substrates of depressionPatricia Robledo, Elena Martín-García, Ester Aso, et al.
European Journal of Pharmacology|June 3, 2014
Baclofen and 2-hydroxysaclofen modify acute hypolocomotive and antinociceptive effects of nicotineAndrés P Varani, Ester Aso, Rafael Maldonado, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Fibrinogen-Derived γ377-395 Peptide Improves Cognitive Performance and Reduces Amyloid-β Deposition, without Altering Inflammation, in AβPP/PS1 MiceEster Aso, Antonio L Serrano, Pura Muñoz-Cánoves, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 27, 2025
Basic Science and PathogenesisPaula Subirana, Núria Sánchez, Francisco Ciruela, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2016
Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based MedicineEster Aso, Pol Andrés-Benito, Margarita Carmona, et al.
Aging|March 12, 2017
Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degenerationPol Andrés-Benito, Jesús Moreno, Ester Aso, et al.
The European Journal of Neuroscience|November 19, 2004
Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in miceGraciela N Balerio, Ester Aso, Fernando Berrendero, et al.
Journal of Alzheimer'S Disease : JAD|August 16, 2014
Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 miceEster Aso, Alexandre Sánchez-Pla, Esteban Vegas-Lozano, et al.
Pharmacology, Biochemistry, and Behavior|February 16, 2025
Striatal dopamine D<sub>2</sub>, adenosine A<sub>2A</sub> and cannabinoid CB<sub>1</sub> receptors balance as a target against non-cognitive symptoms in a mouse model of Alzheimer's diseaseLaura Gómez-Acero, Nuria Sánchez-Fernández, Paula Subirana, et al.
Neurobiology of Disease|November 6, 2025
Thrombospondin-1 regulates synaptic transmission in hippocampal field CA2 and social behavior in miceGerardo Leana-Sandoval, Alexis Madrid, Johanna Extrémet, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Current Pharmaceutical Design|November 5, 2013
Genetically modified mice as tools to understand the neurobiological substrates of depressionPatricia Robledo, Elena Martín-García, Ester Aso, et al.
European Journal of Pharmacology|June 3, 2014
Baclofen and 2-hydroxysaclofen modify acute hypolocomotive and antinociceptive effects of nicotineAndrés P Varani, Ester Aso, Rafael Maldonado, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Fibrinogen-Derived γ377-395 Peptide Improves Cognitive Performance and Reduces Amyloid-β Deposition, without Altering Inflammation, in AβPP/PS1 MiceEster Aso, Antonio L Serrano, Pura Muñoz-Cánoves, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 27, 2025
Basic Science and PathogenesisPaula Subirana, Núria Sánchez, Francisco Ciruela, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2016
Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based MedicineEster Aso, Pol Andrés-Benito, Margarita Carmona, et al.
Aging|March 12, 2017
Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degenerationPol Andrés-Benito, Jesús Moreno, Ester Aso, et al.
The European Journal of Neuroscience|November 19, 2004
Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in miceGraciela N Balerio, Ester Aso, Fernando Berrendero, et al.
Journal of Alzheimer'S Disease : JAD|August 16, 2014
Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 miceEster Aso, Alexandre Sánchez-Pla, Esteban Vegas-Lozano, et al.
Pharmacology, Biochemistry, and Behavior|February 16, 2025
Striatal dopamine D<sub>2</sub>, adenosine A<sub>2A</sub> and cannabinoid CB<sub>1</sub> receptors balance as a target against non-cognitive symptoms in a mouse model of Alzheimer's diseaseLaura Gómez-Acero, Nuria Sánchez-Fernández, Paula Subirana, et al.
Neurobiology of Disease|November 6, 2025
Thrombospondin-1 regulates synaptic transmission in hippocampal field CA2 and social behavior in miceGerardo Leana-Sandoval, Alexis Madrid, Johanna Extrémet, et al.
Pageof 7